ArticleMedicine2025
The short-term effect of Da Vinci's robot total mesorectal excision with preserving the left colic artery.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Mapping the evolving trends of robotic surgery in gastric and colorectal cancer: a clinical trial landscape analysis.Journal of robotic surgery · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer is the second and third most prevalent gastrointestinal tract malignancy among women and men. Over the past few decades, the incidence and mortality of colorectal cancer has gradually increased in China. Many studies have indicated that the robotic surgery system addresses several limitations of laparoscopic surgery and is a safe and feasible surgical approach. However, preservation of the left colic artery (LCA) during robotic total mesorectal excision (R-TME), along with short-term surgical outcomes and complications, has always been the focus of surgeons. Therefore, the present study aimed to analyze the short-term surgical effects of LCA preservation and postoperative complications within 30 days in patients with and without LCA preservation during R-TME. In this retrospective cohort study, we collected and analyzed the clinical data of R-TME performed at the anorectal Department of Gansu Provincial Hospital between January 2018 and January 2023. (In our center, the robotic Da Vinci Xi surgical system is utilized for surgical procedures.) The patients were divided into 2 groups according to whether the LCA was preserved during total mesorectal excision. A total of 150 patients were included in this study; 69 patients underwent LCA preservation, and 81 underwent LCA non-preservation surgeries. In the LCA preservation group, the first postoperative ventilation time (3.2 ± 1.3 days vs 4.2 ± 1.8 days, P = .000) and the time of the first postoperative fluid diet (4.9 ± 1.1 days vs 5.1 ± 1.6 days, P = .001) were significantly improved, and the incidence of protective ileostomy (4.3% vs 14.8%, P = .033) was significantly reduced compared with that in the LCA non-preservation group (P < .05). The overall complication rates within 30 days in the 2 groups were not significantly different. However, the incidence of anastomotic leakage in the LCA preservation group was significantly lower than that in the LCA non-preservation group (0.0% vs 7.4%, P = .021). R-TME is safe and feasible for the preservation of the LCA, and LCA preservation can promote gastrointestinal function recovery. In addition, LCA preservation ensures the extent of No. 253 lymph node dissection, significantly reduces the incidence of anastomotic leakage and ileal protective fistula and improves the patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.